Genefron Ltd

Genefron is specializing in genomic expression based personal diagnostics in viral and autoimmune diseases. We are using gene expression signatures derived from big data analysis, machine learning algorithm and cell biology knowledge. Genefron has already developed its first 3 personal diagnostic kits (PDK) – all CE marked and with Israeli ministry of health approval: IFR 300 In RA (Rheumatoid Arthritis) patients – a PDK predicting treatment outcome of the ‘Anti TNF’ drug family- Sell through Meuhedet HMO IFR 100 In MS (Multiple Sclerosis) patients – a PDK predicting treatment outcome of the ‘Interferon β’ drug family IFR 200 – predicting CMV (cytomegalovirus) transmission to fetus in pregnant women - Can be reimburse by Clalit Mashlim